Tectonic Therapeutic | AVRO - Sales Revenues

Stock Price
27.89
Daily Change
-1.91 -6.41%
Monthly
-6.03%
Yearly
32.87%
Q2 Forecast
28.40

Tectonic Therapeutic reported $0 in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alnylam Pharmaceuticals USD 1.17B 70M Mar/2026
Celltrion KRW 1.15T 180B Mar/2026
Cspc Pharmaceutical CNY 6.11B 502.75M Dec/2025
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Gilead Sciences USD 7B 930M Mar/2026
Ionis Pharmaceuticals USD 246M 43M Mar/2026
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Karyopharm Therapeutics USD 34.08M 3.54M Dec/2025
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
MacroGenics USD 20.8M 20.43M Mar/2026
Medical Developments International AUD 21.57M 12.04M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Organigram Holdings CAD 63.54M 16.52M Dec/2025
Pfizer USD 14.5B 3.08B Mar/2026
Pharma Mar EUR 42.9M 47.3M Mar/2026
Qiagen NV USD 419.22M 38.16M Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Sangamo BioSciences USD 356K 125K Jun/2024
Sanofi EUR 11.24B 60M Mar/2026
Sarepta Therapeutics USD 730.8M 287.9M Mar/2026
Sartorius EUR 899.1M 28.5M Mar/2026
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
Takeda JPY 1.09T 100B Mar/2026
Tilray USD 217.51M 74.75M Dec/2025
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M Mar/2026